SCHEMBL4724441

SCHEMBL4724441

O=C(O)c1cc2nccn2cc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
CASP1 P29466 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
EIF4E P06730 1/20 0.41
EGLN2 Q96KS0 1/20 0.40
NPC1 O15118 1/20 0.40
DHODH Q02127 1/20 0.39
ALPL P05186 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
MAOB P27338 1/20 0.39
KDM4C Q9H3R0 1/20 0.38
SRD5A2 P31213 1/20 0.38
MARS1 P56192 4/20 0.37
KDM4E B2RXH2 1/20 0.36
RAB9A P51151 1/20 0.36
XDH P47989 1/20 0.36
SLC22A12 Q96S37 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1913172 0.89 NPC1 (0.41) SMN1; SMN2EGLN2NPC1MAOBKDM4C
SCHEMBL338815 0.85 ALPL (0.44) EGLN2NPC1ALPLMAOB
SCHEMBL28503211 0.80 MAOB (0.44) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL4196947 0.79 EGLN2 (0.38) EGLN2NPC1MAOBMARS1RAB9A
SCHEMBL4767528 0.79 CNR1 (0.40) TSHRSMN1; SMN2NPC1MAOB
SCHEMBL338509 0.78 TDP1 (0.41) ALDH1A1EGLN2NPC1MAOBKDM4E
SCHEMBL339621 0.78 EGLN2 (0.41) EGLN2NPC1MAOB
SCHEMBL1913156 0.78 EGLN2 (0.41) EGLN2NPC1KDM4E
SCHEMBL29229563 0.76 MAOB (0.43) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL339104 0.75 KDM4E (0.45) EGLN2NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004643-A1 ORGANIC COMPOUNDS Novartis AG (CH) 2008-12-24 EP disclosed
WO-2007113226-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2007-10-11 WO disclosed